TD Cowen Reiterates Buy Rating on Avidity Biosciences (RNA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St eyes best day in a month as Anthropic's IPO filing propels AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| PROSENSA HOLD (NASDAQ: RNA) | Delayed: 8.15 -0.05 (0.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.20 | 52 Week High | $22.80 | |||
| Open | $8.20 | 52 Week Low | $4.12 | |||
| Day High | $8.23 | P/E | N/A | |||
| Day Low | $8.02 | EPS | $0.00 | |||
| Volume | 85,589 | |||||
